REFERENCES
- Wacker W B, Lipton M M. Experimental allergic uveitis. I. Homologous retina as uveitogenic antigen. Nature, 206: 253, [CSA]
- Wacker W B, Donoso L A, Kalso C M, Yankeelov J A, Organisciak D T. Experimental autoimmune uveitis. Isolation, characterization of a soluble uveitopathogenic antigen from bovine retina. J Immunol 1977; 119: 1949–1958, [INFOTRIEVE], [CSA]
- De Kozak Y, Sakai J, Thillaye B, Faure J P. S-antigen induced experimental autoimmuneuveo-retinitis in rats. Curr Eye Res 1981; 1: 327–337, [INFOTRIEVE], [CSA]
- Mochizuki M, Kuabara T, McAlister C, Nussenblatt R B, Gery I. Adoptive transfer of experimental autoimmune uveitoretinitis in rats: Immunopathogenic mechanisms and histological features. Invest Ophthalmol Vis Sci 1985; 26: 1–14, [INFOTRIEVE], [CSA]
- Donoso L A, Yamaki K, Merryman C F, Shinohara T, Yue S, Sery T W. Human S-antigen characterization of uveitopathogenic sites. Curr Eye Res 1988; 7: 1077–1085, [INFOTRIEVE], [CSA]
- Donoso L A, Gregerson D S, Fling S P, Merryman C F, Sery T W. The use of synthetic peptides in the study of experimental autoimmune uveitis. Curr Eye Res 1990; 9: 155–161, [INFOTRIEVE], [CSA]
- Liou G I, Bridges C DB, Fong S-L, Alvarez R A, Gonzalez-Fernandez F. Vitamin A transport between retina and pigment epithelium—an interstitial protein carrying endogenous retinol (interstitial retinol-binding protein). Vis Res 1982; 22: 1457–1467, [INFOTRIEVE], [CSA], [CROSSREF]
- Donoso L, Merryman C F, Sery T W, Vrabec T, Arbizo V, Fong S-L. Human IRBP: characterization of uveitopathogenic sites. Curr Eye Res 1988; 7: 1087–1095, [INFOTRIEVE], [CSA]
- Donoso L A, Merryman C F, Sery T W, Sanders R, Vrabec T, Fong S-L. Human interstitial retinoid binding protein. A potent uveitopathogenic agent for the induction of experimental autoimmune uveitis. J Immunol 1989; 143: 79–83, [INFOTRIEVE], [CSA]
- Ngwenya B Z, Yamamoto N. Effect of inflammation products on immune systems: lysophosphatidylcholine stimulates macrophages. Cancer Immunol Immunother 1986; 21: 174–182, [INFOTRIEVE], [CSA], [CROSSREF]
- Yamamoto N, Ngwenya B Z, Sery T W, Pieringer R A. Activation of macrophages by ether analogs of lysophospholipids. Cancer Immunol Immunother 1987; 25: 185–192, [INFOTRIEVE], [CSA], [CROSSREF]
- Yamamoto N. Vitamin D3 and the immune system. Encyclopedia of Immunology, 2nd Edition, Peter J. Delves, Ivan Roitt. Academic Press Ltd. 2494–2499
- Yamamoto N, Homa S. Vitamin D3-binding protein (group-specific component, Gc) is a precursor for the macrophage activating signal from lysophosphotidylcholine-treated lymphocytes. Proc Natl Acad Sci USA 1991; 88: 8539–8543, [INFOTRIEVE], [CSA], [CROSSREF]
- Yamamoto N, Kumashiro R. Conversion of vitamin D3-binding protein (Group-specific component) to a macrophage activating factor by the stepwise action of B-galactosidase of B cells and sialidase of T cells. J Immunol 1993; 151: 2794–2902, [INFOTRIEVE], [CSA]
- Yamamoto N, St. Claire D A, Homa S, Ngwenya B Z. Activation of mouse macrophages by alkylglycerols, inflammation products of cancerous tissues. Cancer Res 1988; 48: 6044–6049, [INFOTRIEVE], [CSA]
- Yamamoto N, Urade M, Ueda M. Potent tumoricidal capacity of macrophages activated by Gc protein-derived macrophage activating factor (GcMAF) and its therapeutic efficacy for prostate, breast and colorectal cancers. J Immunother 2005; 28: 642, [CSA], [CROSSREF]
- Yamamoto N. Structural definition of a potent macrophage activating factor derived from Vitamin D3-binding protein with adjuvant activity for antibody production. Mol Immunol 1996; 33: 1157–164, [INFOTRIEVE], [CSA], [CROSSREF]
- Yamamoto N, Naraparaju V. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization. Immunol Cell Biol 1998; 76: 237–244, [INFOTRIEVE], [CSA], [CROSSREF]
- Avrameas S, Ternynck T. Peroxidase labeled antibody and Fab conjugates with enhanced intracellular penetration. Immunochemistry 1971; 8: 1175, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang S, Cardon-Cardo C, Zhang H S, Reuter V E, Adluri S, Hamilton W B, Loyd K O, Livingston P O. Selection of tumor antigen as targets for immune attack using Immunohistochemistry. I. Focus on gangliosides. Int J Cancer 1997; 73: 42–49, [INFOTRIEVE], [CSA], [CROSSREF]
- Zhang S, Zhang H S, Reuter V E, Slovin F S, Scher H I, Livingston P O. Expression of potential target antigens for immunotherapy on primary metastatic prostate cancers. Clin Cancer Res 1998; 4: 293–302, [CSA]
- Ragupathi G, Livingston P O, Hood C, Gathuru J, Krown S E, Chapnab B, Wolchok H D, Williams H J, Oldfield R C, Hwu W. Consistent antibody response against ganglioside GD2 lactone keyholelimpet hemocyanin conjugate vaccine plus immunological adjuvant QS-21. Clin Cancer Res, 9: 5214–5220, [CSA]
- Kensil C R, Patel U, Lennick M, Marciani D. Separation and characterization of saponins with adjuvant activity from Quiiaja saponaria Molina cortex. J Immunol 1991; 146: 431–437, [INFOTRIEVE], [CSA]